Biogen (BIIB) Raised Prices Again on MS Drugs, Cowen Notes
Tweet Send to a Friend
Cowen analyst Eric Schmidt noted that third-party sources indicate Biogen (NASDAQ: BIIB) enacted a 6.0% price hike on Tecfidera, Avonex ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE